Picture of Xcelerate logo

XCRT Xcelerate Income Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro Cap

Annual income statement for Xcelerate, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2006
December 31st
2007
December 31st
2010
December 31st
2011
December 31st
2012
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10KSB10KSBPRESSPRESSPRESS
Standards:
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Revenue
Other Revenue
Total Revenue2.22.593.863.994.26
Cost of Revenue
Gross Profit1.752.073.052.923
Selling / General / Administrative Expenses
Depreciation and Amortization
Total Operating Expenses3.13.233.283.944.18
Operating Profit-0.903-0.6420.5760.0560.075
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes-2.02-0.8840.471-0.13-0.108
Provision for Income Taxes
Net Income After Taxes-2.02-0.8840.471-0.13-0.108
Net Income Before Extraordinary Items
Net Income-2.02-0.8840.471-0.13-0.108
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income-2.02-0.8840.471-0.13-0.108
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-0.05-0.0120.002-0.001-0.001
Dividends per Share